» Articles » PMID: 2040695

Exon Skipping During Splicing of Dystrophin MRNA Precursor Due to an Intraexon Deletion in the Dystrophin Gene of Duchenne Muscular Dystrophy Kobe

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1991 Jun 1
PMID 2040695
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Recent molecular studies have shown that in a patient with Duchenne muscular dystrophy (DMD) Kobe, the size of exon 19 of the dystrophin gene was reduced to 36 bp due to the deletion of 52 bp out of 88 bp of the exon. The consensus sequences at the 5' and 3' splice sites of exon 19 were unaltered (Matsuo, M., et al. 1990. Biochem. Biophys. Res. Commun. 170:963-967). To further elucidate the molecular nature of the defect, we examined the primary structure of cytoplasmic dystrophin mRNA of the DMD Kobe patient across the junctions of exons 18, 19, and 20 by gel electrophoresis and sequencing of polymerase chain reaction-amplified cDNA. The mRNA coding for dystrophin was reverse transcribed using random primers, and the cDNA was then enzymatically amplified in vitro. The targeted fragment was smaller than expected from the genomic DNA analysis. By sequencing of the amplified product, we found that exon 18 was joined directly to exon 20, so that exon 19 was completely absent, suggesting that this exon was skipped during processing of the dystrophin mRNA precursor. All other bases in the amplified product were unaltered. Therefore, the data strongly suggest that the internal exon deletion generates an abnormally spliced mRNA in which the sequence of exon 18 is joined to the sequence of exon 20. We propose that the deletion is responsible for abnormal processing of the DMD Kobe allele. This finding has important implications regarding the determinants of a functional splice site.

Citing Articles

Expansion of Splice-Switching Therapy with Antisense Oligonucleotides.

Takeshima Y Int J Mol Sci. 2025; 26(5).

PMID: 40076889 PMC: 11899878. DOI: 10.3390/ijms26052270.


30 Years Since the Proposal of Exon Skipping Therapy for Duchenne Muscular Dystrophy and the Future of Pseudoexon Skipping.

Matsuo M Int J Mol Sci. 2025; 26(3).

PMID: 39941071 PMC: 11818380. DOI: 10.3390/ijms26031303.


Duchenne muscular dystrophy caused by a deletion (c.5021del) in exon 35 of the DMD gene: A case report and review of the literature.

Liu Y, Tang Y, Zhang H, Chen H, Luo Q, Liu J Heliyon. 2024; 10(7):e28677.

PMID: 38586344 PMC: 10998125. DOI: 10.1016/j.heliyon.2024.e28677.


A novel splice variant of the human MSTN gene encodes a myostatin-specific myostatin inhibitor.

Maeta K, Farea M, Nishio H, Matsuo M J Cachexia Sarcopenia Muscle. 2023; 14(5):2289-2300.

PMID: 37582652 PMC: 10570081. DOI: 10.1002/jcsm.13314.


Emerging Oligonucleotide Therapeutics for Rare Neuromuscular Diseases.

Aoki Y, Wood M J Neuromuscul Dis. 2021; 8(6):869-884.

PMID: 34092651 PMC: 8673547. DOI: 10.3233/JND-200560.


References
1.
Treisman R, Orkin S, Maniatis T . Specific transcription and RNA splicing defects in five cloned beta-thalassaemia genes. Nature. 1983; 302(5909):591-6. DOI: 10.1038/302591a0. View

2.
Kontusaari S, Tromp G, Kuivaniemi H, Ladda R, Prockop D . Inheritance of an RNA splicing mutation (G+ 1 IVS20) in the type III procollagen gene (COL3A1) in a family having aortic aneurysms and easy bruisability: phenotypic overlap between familial arterial aneurysms and Ehlers-Danlos syndrome type IV. Am J Hum Genet. 1990; 47(1):112-20. PMC: 1683756. View

3.
REED R, Maniatis T . A role for exon sequences and splice-site proximity in splice-site selection. Cell. 1986; 46(5):681-90. DOI: 10.1016/0092-8674(86)90343-0. View

4.
Green M . Pre-mRNA splicing. Annu Rev Genet. 1986; 20:671-708. DOI: 10.1146/annurev.ge.20.120186.003323. View

5.
Marvit J, DiLella A, Brayton K, Ledley F, Robson K, Woo S . GT to AT transition at a splice donor site causes skipping of the preceding exon in phenylketonuria. Nucleic Acids Res. 1987; 15(14):5613-28. PMC: 306010. DOI: 10.1093/nar/15.14.5613. View